Product Details for NDA 021460
METAGLIP (GLIPIZIDE; METFORMIN HYDROCHLORIDE)
2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: GLIPIZIDE; METFORMIN HYDROCHLORIDE
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 001
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
METAGLIP (GLIPIZIDE; METFORMIN HYDROCHLORIDE)
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;250MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 001
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: GLIPIZIDE; METFORMIN HYDROCHLORIDE
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 002
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
METAGLIP (GLIPIZIDE; METFORMIN HYDROCHLORIDE)
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 2.5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 002
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Marketing Status: Discontinued
Active Ingredient: GLIPIZIDE; METFORMIN HYDROCHLORIDE
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 003
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: METAGLIP
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 5MG;500MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Reference Listed Drug: Yes
Reference Standard: No
TE Code:
Application Number: N021460
Product Number: 003
Approval Date: Oct 21, 2002
Applicant Holder Full Name: BRISTOL MYERS SQUIBB CO
Marketing Status: Discontinued
Patent and Exclusivity Information